Jonathan Yong
Stock Analyst at UBS
(2.71)
# 1,846
Out of 5,163 analysts
95
Total ratings
62.96%
Success rate
12.19%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Neutral | $12 → $17 | $13.23 | +28.50% | 10 | Jan 9, 2026 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $1.56 | +220.51% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $1.98 | +51.52% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $13.62 | -11.89% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.24 | +257.14% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $9.43 | +175.72% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $24.77 | -43.48% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $75.57 | +27.03% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $16.25 | +96.92% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $18.90 | +455.56% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $100.37 | -20.29% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $263.80 | -12.43% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $5.37 | +402.79% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $217.08 | -53.93% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $940.91 | -52.17% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $1.13 | +961.95% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $5.62 | +1,145.55% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $19.54 | -13.00% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $149.20 | +134.58% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $23.52 | +303.91% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $1.59 | +434.59% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $21.68 | +89.11% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.20 | +165.63% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $79.51 | +6.90% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $199.70 | -26.89% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $34.45 | +207.69% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $192.42 | -18.41% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $267.19 | +37.73% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $165.43 | +283.85% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $76.13 | +53.68% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $19.56 | +53.37% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $532.97 | -44.09% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $227.63 | -58.27% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $282.09 | +75.48% | 1 | Oct 15, 2021 |
Oscar Health
Jan 9, 2026
Upgrades: Neutral
Price Target: $12 → $17
Current: $13.23
Upside: +28.50%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $1.56
Upside: +220.51%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $1.98
Upside: +51.52%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $13.62
Upside: -11.89%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.24
Upside: +257.14%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $9.43
Upside: +175.72%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $24.77
Upside: -43.48%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $75.57
Upside: +27.03%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $16.25
Upside: +96.92%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $18.90
Upside: +455.56%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $100.37
Upside: -20.29%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $263.80
Upside: -12.43%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $5.37
Upside: +402.79%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $217.08
Upside: -53.93%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $940.91
Upside: -52.17%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $1.13
Upside: +961.95%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $5.62
Upside: +1,145.55%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $19.54
Upside: -13.00%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $149.20
Upside: +134.58%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $23.52
Upside: +303.91%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $1.59
Upside: +434.59%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $21.68
Upside: +89.11%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.20
Upside: +165.63%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $79.51
Upside: +6.90%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $199.70
Upside: -26.89%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $34.45
Upside: +207.69%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $192.42
Upside: -18.41%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $267.19
Upside: +37.73%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $165.43
Upside: +283.85%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $76.13
Upside: +53.68%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $19.56
Upside: +53.37%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $532.97
Upside: -44.09%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $227.63
Upside: -58.27%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $282.09
Upside: +75.48%